An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy

NCT01343914 · clinicaltrials.gov ↗
COMPLETED
Status
118
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche